The Official Medicare Set Aside Blog And Information Resource

The Opioid Crisis . . . Is It Still a Crisis?

Medicare Set-Aside Blog, Opioids, Rx/Pharmacy on February 4, 2020
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

During the past year and a half, we’ve detailed the efforts of the federal government and many state governments to combat the opioid crisis. We devoted a blog series to the Department of Health and Human Services’ five-part strategy to curb the epidemic. We’ve discussed educational efforts for prescribers and revisions to prescribing guidelines which […] Continue

Acupuncture Is Coming Soon to an MSA Near You: CMS Issues Decision to Cover Acupuncture for Medicare Beneficiaries

CMS, Medicare, Medicare Set-Aside Blog, MSP News, Opioids on January 22, 2020
Posted by Jean S. Goldstein, JD, CMSP

Yesterday, CMS issued a decision to cover acupuncture for Medicare patients with chronic low back pain (cLBP) to some extent.  You may recall that CMS previously issued a proposed decision to cover acupuncture, as we discussed here on our blog.  CMS’ final coverage decision memo can be found here, and indicates that acupuncture for chronic […] Continue

Department of Health and Human Services Issues New Opioid Guidelines

Medicare Set-Aside Blog, Opioids, Rx/Pharmacy on December 18, 2019
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

This past July, CMS issued an educational piece that warned of the dangers associated with the concurrent use of opioids and benzodiazepines. You may have seen our blog on the CMS publication. If you missed that blog, you can read it here. In October, the Department of Health and Human Services (HHS) issued guidelines on […] Continue

Behind the Counter Availability of Naloxone

Medicare Set-Aside Blog, Medicare Set-Asides, Opioids, Rx/Pharmacy on October 2, 2019
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

One component of the FDA’s drug approval process is a designation of the drug as prescription only or over-the-counter (OTC). If a drug is initially approved as a prescription only medication, this doesn’t mean that the drug cannot later be approved for over-the-counter status. In order to facilitate this change, the drug manufacturer files a […] Continue

CMS Issues Education Regarding Concurrent Use of Opioids and Benzodiazepines

CMS, Medicare Set-Aside Blog, Opioids, Rx/Pharmacy on September 24, 2019
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

On July 1st, CMS issued a Medicare Learning Network (MLN) article regarding the potential dangers associated with the concurrent use of opioids and benzodiazepines. This combination of drugs has always been prescribed cautiously in light of the depressive effect that both drugs can have on a patient’s ability to breathe. When used together, the resulting […] Continue